Consumption of cephalosporins in the community, European Union/European Economic Area, 1997–2017.

Autor: Versporten, Ann, Bruyndonckx, Robin, Adriaenssens, Niels, Hens, Niel, Monnet, Dominique L, Molenberghs, Geert, Goossens, Herman, Weist, Klaus, Coenen, Samuel, the ESAC-Net study group, Strauss, Reinhild, Vandael, Eline, Sabtcheva, Stefana, Payerl-Pal, Marina, Kyriakidou, Isavella, Vlček, Jiří, Sönksen, Ute Wolff, Linask, Elviira, Sarvikivi, Emmi, Hider-Mlynarz, Karima
Předmět:
Zdroj: Journal of Antimicrobial Chemotherapy (JAC); 2021 Supplement, pii22-ii29, 8p
Abstrakt: Objectives: Data on cephalosporin consumption in the community were collected from 30 EU/EEA countries over two decades. This article reviews temporal trends, seasonal variation, presence of change-points and changes in the composition of the main subgroups of cephalosporins. Methods: For the period 1997–2017, data on consumption of cephalosporins (i.e. first-, second-, third- and fourth-generation cephalosporins; ATC subgroups J01DB, J01DC, J01DD and J01DE, respectively) in the community and aggregated at the level of the active substance, were collected using the WHO ATC/DDD methodology (ATC/DDD index 2019). Consumption was expressed in DDD per 1000 inhabitants per day and in packages per 1000 inhabitants per day. Cephalosporin consumption was analysed based on ATC-4 subgroup, and presented as trends, seasonal variation, presence of change-points and compositional changes. Results: In 2017, cephalosporin consumption in the community expressed in DDD per 1000 inhabitants per day varied by a factor of 285 between countries with the highest (Greece) and the lowest (the Netherlands) consumption. Cephalosporin consumption did not change significantly between the first quarter of 1997 and the last quarter of 2017. Seasonal variation decreased significantly over time. Proportional consumption of second- and third-generation cephalosporins significantly increased over time compared with that of first-generation cephalosporins, and proportional consumption of fourth-generation cephalosporins significantly decreased compared with that of second- and third-generation cephalosporins. Conclusions: Despite considerable variation between countries in the composition of cephalosporin consumption and trends over time, a significant shift towards consumption of more broad-spectrum cephalosporins in the community was observed across the EU/EEA during 1997–2017. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index